Nisa Investment Advisors LLC Buys 3,370 Shares of Intuitive Surgical, Inc. $ISRG

Nisa Investment Advisors LLC lifted its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 3.2% in the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 109,861 shares of the medical equipment provider’s stock after purchasing an additional 3,370 shares during the period. Nisa Investment Advisors LLC’s holdings in Intuitive Surgical were worth $62,221,000 at the end of the most recent quarter.

Other hedge funds also recently modified their holdings of the company. Rakuten Investment Management Inc. bought a new position in Intuitive Surgical during the third quarter valued at $388,436,000. Assenagon Asset Management S.A. increased its position in Intuitive Surgical by 106.6% in the fourth quarter. Assenagon Asset Management S.A. now owns 1,533,771 shares of the medical equipment provider’s stock worth $868,667,000 after buying an additional 791,516 shares during the last quarter. Amundi raised its stake in shares of Intuitive Surgical by 29.7% in the third quarter. Amundi now owns 3,227,472 shares of the medical equipment provider’s stock valued at $1,451,362,000 after buying an additional 739,444 shares during the period. Sands Capital Management LLC raised its stake in shares of Intuitive Surgical by 77.0% in the third quarter. Sands Capital Management LLC now owns 1,341,109 shares of the medical equipment provider’s stock valued at $599,784,000 after buying an additional 583,539 shares during the period. Finally, Victory Capital Management Inc. lifted its position in shares of Intuitive Surgical by 41.3% during the 3rd quarter. Victory Capital Management Inc. now owns 1,941,310 shares of the medical equipment provider’s stock valued at $868,212,000 after buying an additional 567,483 shares during the last quarter. Institutional investors own 83.64% of the company’s stock.

Intuitive Surgical Stock Performance

Intuitive Surgical stock opened at $460.99 on Wednesday. The stock has a market cap of $163.71 billion, a P/E ratio of 58.43, a PEG ratio of 3.49 and a beta of 1.66. Intuitive Surgical, Inc. has a fifty-two week low of $425.00 and a fifty-two week high of $603.88. The firm’s fifty day moving average price is $491.53 and its 200-day moving average price is $513.74.

Intuitive Surgical (NASDAQ:ISRG) last issued its quarterly earnings data on Thursday, January 22nd. The medical equipment provider reported $2.53 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.27 by $0.26. Intuitive Surgical had a return on equity of 15.06% and a net margin of 28.38%.The company had revenue of $2.87 billion for the quarter, compared to the consensus estimate of $2.72 billion. During the same quarter last year, the business posted $2.21 earnings per share. The firm’s revenue was up 18.8% compared to the same quarter last year. Sell-side analysts predict that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current year.

Insiders Place Their Bets

In other news, EVP Myriam Curet sold 421 shares of the business’s stock in a transaction dated Wednesday, February 11th. The stock was sold at an average price of $494.96, for a total transaction of $208,378.16. Following the completion of the transaction, the executive vice president owned 409 shares of the company’s stock, valued at approximately $202,438.64. The trade was a 50.72% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, SVP Mark Brosius sold 2,362 shares of the company’s stock in a transaction that occurred on Wednesday, March 4th. The stock was sold at an average price of $498.68, for a total transaction of $1,177,882.16. Following the completion of the transaction, the senior vice president owned 3,554 shares in the company, valued at approximately $1,772,308.72. This trade represents a 39.93% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Over the last three months, insiders sold 32,943 shares of company stock worth $17,279,568. 0.60% of the stock is owned by corporate insiders.

Wall Street Analyst Weigh In

Several research firms have recently weighed in on ISRG. Royal Bank Of Canada increased their price target on Intuitive Surgical from $625.00 to $650.00 and gave the stock an “outperform” rating in a research note on Wednesday, December 17th. Wells Fargo & Company boosted their price objective on Intuitive Surgical from $600.00 to $654.00 and gave the company an “overweight” rating in a research note on Friday, December 12th. Argus cut their target price on shares of Intuitive Surgical from $630.00 to $560.00 and set a “buy” rating for the company in a research report on Wednesday, February 4th. Zacks Research downgraded shares of Intuitive Surgical from a “strong-buy” rating to a “hold” rating in a research note on Monday. Finally, TD Cowen raised shares of Intuitive Surgical to a “strong-buy” rating in a research report on Tuesday, January 27th. One research analyst has rated the stock with a Strong Buy rating, sixteen have issued a Buy rating, seven have given a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $614.95.

Intuitive Surgical News Summary

Here are the key news stories impacting Intuitive Surgical this week:

• Positive Sentiment: Analyst/technical optimism: Commentary noting ISRG is technically oversold and that Wall Street estimate revisions are tilting upward is supporting a near-term bounce and buy-the-dip demand. Down 10.1% in 4 Weeks, Here’s Why Intuitive Surgical (ISRG) Looks Ripe for a Turnaround
• Positive Sentiment: Fundamentals remain supportive: Intuitive posted an EPS and revenue beat in its latest quarter with healthy margins and double‑digit revenue growth year-over-year — this gives investors confidence that demand for robot-assisted procedures and consumables can reaccelerate. (See company reports and recent earnings commentary.)
• Neutral Sentiment: Market recap: Recent news pieces note ISRG rose but still lagged the broader market on the session, reflecting mixed investor appetite versus larger-cap growth peers. Intuitive Surgical, Inc. (ISRG) Rises But Trails Market: What Investors Should Know
• Neutral Sentiment: Sector/peer headlines may influence sentiment: Big moves in med‑tech peers (large drawdowns at some names and product launches at others) are creating rotation and headline-driven volatility that can impact ISRG. Examples include coverage of Boston Scientific’s selloff and Baxter’s new IV labeling system. Can Boston Scientific Stock Surge 40% From Here? Baxter International Unveils IV Verify to Enhance IV Labeling Accuracy
• Negative Sentiment: Technical and momentum concerns remain: ISRG has been through a recent pullback (50‑day moving average below the 200‑day) and a multi-week decline that could keep downside risk elevated if procedure volumes or guidance disappoint. Investors should watch upcoming volumes, guidance, and margin commentary closely.

About Intuitive Surgical

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.